The present invention provides a vector system comprising a nucleotide sequence coding for an antibody. In particular, the present invention relates to the use of such a vector system in a subject, where the nucleotide sequence is expressed in vivo to produce said antibody.

 
Web www.patentalert.com

< Quinoxalinyl tripeptide hepatitis C virus inhibitors

> Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

> HIV-1 mutations selected for by .beta.-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine
~ 00569